Drug delivery device, method of manufacture, and method of use

Patent metadata

Field	Value
Publication number	US-12201809-B2
Application number	US-202117386659-A
Country	US
Kind code	B2
Filing date	Jul 28, 2021
Priority date	Apr 8, 2016
Publication date	Jan 21, 2025
Grant date	Jan 21, 2025

Abstract

Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor (G-CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device may include a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector may define a sterile fluid flowpath between the container and the insertion mechanism. Optionally, a cannula initially disposed about the needle may be included. The cannula may be retained in the patient at an injection site created by the needle after the needle is withdrawn from the patient. Methods of assembly and operation are also provided.

First claim

What is claimed is:

1. A wearable drug delivery device comprising:
a housing;
a container disposed at least partially within the housing;
a plunger movably disposed within the container; and
a drive mechanism disposed at least partially within the housing and comprising:
a spring configured to move the plunger within the container when released, wherein at least a portion of the plunger is disposed within at least a portion of the spring,
a gear operably coupled to the plunger,
a lever operably coupled to the gear, and
an electrical actuator configured to oscillate the lever to cause the gear to rotate in increments,
wherein, to oscillate the lever, the electrical actuator is configured to selectively drive the lever in a first direction and a second direction.

2. The wearable drug delivery device of claim 1 , wherein the gear includes a plurality of teeth and the lever is configured to selectively engage the teeth when oscillating.

3. The wearable drug delivery device of claim 1 , comprising:
a needle; and
an insertion mechanism configured to move the needle between a retracted position and an inserted position.

4. The wearable drug delivery device of claim 3 , wherein the insertion mechanism comprises a rotational biasing member.

5. The wearable drug delivery of claim 4 , the insertion mechanism comprising a hub operably coupled to the needle and an insertion mechanism housing, wherein the rotational biasing member configured to rotate the insertion mechanism housing.

6. The wearable drug delivery of claim 5 , wherein the insertion mechanism housing is operably coupled to the hub such that initial rotation of the insertion mechanism housing causes the needle to move axially from the retracted position to the insertion position.

7. The wearable drug delivery of claim 6 , wherein the insertion mechanism housing comprises a cylindrical portion and at least a portion of the needle is positioned within the cylindrical portion when the needle is in the retracted position.

8. The wearable drug delivery of claim 6 , wherein the insertion mechanism housing comprises a first guide surface and the hub comprises an outwardly extending follower configured to slidably engage the first guide surface during rotation of the insertion mechanism housing.

9. The wearable drug delivery of claim 8 , wherein at least a portion of the first guide surface extends in an axial direction and a circumferential direction.

10. The wearable drug delivery of claim 5 , wherein the insertion mechanism housing is rotatable about a rotational axis and the rotational axis is parallel to a longitudinal axis of the needle.

11. The wearable drug delivery of claim 5 , comprising a first abutment member having a first position wherein the first abutment member engages the insertion mechanism housing to prevent the rotational biasing member from rotating the insertion mechanism housing and second position wherein the first abutment member is disengaged from the insertion mechanism housing to allow the rotational biasing member to rotate the insertion mechanism housing.

12. The wearable drug delivery of claim 11 , wherein the insertion mechanism housing includes a cylindrical portion and a second abutment member extending outwardly from the cylindrical portion, the second abutment member engaging the first abutment member when the first abutment member is in the first position.

13. The wearable drug delivery of claim 3 , wherein the insertion mechanism is at least partially disposed within the housing.

14. The wearable drug delivery of claim 1 , comprising an adhesive applied to an exterior surface of the housing for attaching the housing to skin of a patient.

15. The wearable drug delivery device of claim 1 , comprising a drug disposed in the container, the drug comprising at least one of: a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) specific antibody, a granulocyte colony-stimulating factor (G-CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody.

16. The wearable drug delivery device of claim 1 , wherein the spring comprises a coiled spring.

17. The wearable drug delivery device of claim 16 , wherein the coiled spring is configured to bear upon a surface of the plunger.

18. A wearable drug delivery device comprising:
a housing;
a container disposed at least partially within the housing;
a plunger movably disposed within the container;
a drive mechanism disposed at least partially within the housing and comprising:
a biasing member configured to move the plunger within the container when released,
a gear operably coupled to the plunger,
a lever operably coupled to the gear, and
an electrical actuator configured to oscillate the lever to cause the gear to rotate in increments;

a needle; and
an insertion mechanism configured to move the needle between a retracted position and an inserted position, wherein the insertion mechanism comprises a rotational biasing member and a hub operably coupled to the needle and an insertion mechanism housing, wherein the rotational biasing member configured to rotate the insertion mechanism housing.

19. A wearable drug delivery device comprising:
a housing;
a container disposed at least partially within the housing;
a plunger movably disposed within the container; and
a drive mechanism disposed at least partially within the housing and comprising:
a spring configured to move the plunger within the container when released, wherein at least a portion of the plunger is disposed within at least a portion of the spring,
a gear operably coupled to the plunger,
a lever operably coupled to the gear, and
an electrical actuator configured to oscillate the lever to cause the gear to rotate in increments,
wherein the electrical actuator is configured to output linear motion.

20. The wearable drug delivery device of claim 19 , wherein the electrical actuator comprises a linear solenoid.

21. A wearable drug delivery device comprising:
a housing;
a container disposed at least partially within the housing;
a plunger movably disposed within the container;
a drive mechanism disposed at least partially within the housing and comprising:
a spring configured to move the plunger within the container when released, wherein at least a portion of the plunger is disposed within at least a portion of the spring,
a gear operably coupled to the plunger,
a lever operably coupled to the gear, and
an electrical actuator configured to oscillate the lever to cause the gear to rotate in increments; and

an insertion mechanism disposed at least partially within the housing, wherein the insertion mechanism comprises:
a delivery member moveable between a first position wherein an insertion portion of the delivery member is disposed within the housing and a second position wherein the insertion portion of the delivery member is disposed exterior to the housing for insertion into a patient,
a rotatable member,
a rotational biasing member configured to rotate the rotatable member, and
a hub operably coupled with the rotatable member and the delivery member.

Assignees

• Amgen Inc

Inventors

• Gibson Scott R
• Moberg Sheldon B
• Taha Basel Hasan
• Boyaval Margaux Frances
• Destefano Mark A
• Laurence Lawton
• Love John C
• Hanson Ian B
• Bente Iv Paul F
• Clemente Matthew J
• Ubach Antonio
• Ramaswamy Rajan
• Codd Daniel S
• Beaver Scott
• Bokelman Kevin L
• Dardani Ian P
• O'Connor Sean M
• Feldman Danielle

Classifications

• A61M2205/8206

  battery-operated · CPC title

• A61M2205/36

  related to heating or cooling · CPC title

• A61M2205/3592

  using telemetric means, e.g. radio or optical transmission · CPC title

• A61M2205/3584

  using modem, internet or Bluetooth® · CPC title

• A61M2205/3561

  local, e.g. within room or hospital · CPC title